Molecular Mechanisms Underlying Drug Resistance of the MCF7/ADR Breast Cancer Cell Line
- 作者: Bogush T.A.1, Kalyuzhny S.A.1, Chetyrkina M.R.2, Yastrebova M.A.1,2, Scherbakov A.M.1, Ryabinina O.M.1, Mamichev I.A.1, Bogush E.A.1, Kamensky A.A.2
-
隶属关系:
- Blokhin National Medical Research Center of Oncology
- Department of Biology
- 期: 卷 73, 编号 5 (2018)
- 页面: 248-250
- 栏目: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/163751
- DOI: https://doi.org/10.3103/S0027131418050036
- ID: 163751
如何引用文章
详细
Drug-sensitive MCF7 cells and drug-resistant MCF7/ADR cells are shown to differ with regard to the vimentin and P-gp expression levels, which is indicative of the coexistence of two drug resistance mechanisms in MCF7/ADR cells. The mesenchymal phenotype of epithelial cells makes a much greater contribution to the resistance mechanisms than the ABC transporter’s overexpression, since the difference in the vimentin expression levels in drug-sensitive and drug-resistant cultures is significantly higher than the difference in the P-gp expression.
作者简介
T. Bogush
Blokhin National Medical Research Center of Oncology
编辑信件的主要联系方式.
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
S. Kalyuzhny
Blokhin National Medical Research Center of Oncology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
M. Chetyrkina
Department of Biology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow, 119991
M. Yastrebova
Blokhin National Medical Research Center of Oncology; Department of Biology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow; Moscow, 119991
A. Scherbakov
Blokhin National Medical Research Center of Oncology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
O. Ryabinina
Blokhin National Medical Research Center of Oncology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
I. Mamichev
Blokhin National Medical Research Center of Oncology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
E. Bogush
Blokhin National Medical Research Center of Oncology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow
A. Kamensky
Department of Biology
Email: tatbogush@mail.ru
俄罗斯联邦, Moscow, 119991
补充文件
